Bioera
ISIN
IT0005516130
Ticker
BIE
Sector
Sub-Industry
Country
Italy
Year Founded
2004
ISIN
IT0005516130
Ticker
BIE
Sector
Sub-Industry
Country
Italy
Year Founded
2004
Bioera S.P.A. produces and sells herbal remedies and cosmetics. The Company provides organic products, natural cosmetics, and traditional food products. Bioera serves customers in Italy.
Bioera is the leader of a group of companies specialising in the production and sale of organic products, natural cosmetics and traditional food products.
The group, created in 2004, is today one of the main operators within the sector, with a portfolio of its own brands, including KI, Crudigno and Fonte della Vita, and distributes products by outsourcers.
Bioera’s philosophy is to dynamically and constantly monitor the modern consumer’s attention to, and awareness of health and well-being.
The aim of Bioera, led by a growing interest in organic products, is to promote a natural lifestyle and a true culture of well-being through its products, which respect both humans and nature.
With Bioera, well-being becomes truly organic.
3
Europe
| Line item in (eur) | 01.01.2020 | 01.01.2021 | 01.01.2022 |
|---|---|---|---|
| Noncurrent Loans And Receivables | N/A | 135,000.00 | 956,000.00 |
| Current Loans And Receivables | N/A | 562,000.00 | 989,000.00 |
| Cash and cash equivalents | 191,000.00 | 141,000.00 | 28,000.00 |
| Longterm Borrowings | N/A | 6,686,000.00 | 3,260,000.00 |
| Trade And Other Current Payables To Trade Suppliers | N/A | 6,445,000.00 | 1,742,000.00 |
| Current Borrowings And Current Portion Of Noncurrent Borrowings | N/A | 6,220,000.00 | 4,389,000.00 |
| Line item in (eur) | 01.01.2020/ 01.01.2021 |
01.01.2021/ 01.01.2022 |
|---|---|---|
| Services Expense | 5,154,000.00 | 1,902,000.00 |
| Depreciation Expense | 146,000.00 | 77,000.00 |
| Amortisation Expense | 36,000.00 | 0.00 |
| Profit (loss) | -5,307,000.00 | 15,347,000.00 |
| Line item in (eur) | 01.01.2020 | 01.01.2021 | 01.01.2022 |
|---|---|---|---|
| Profit (loss) | N/A | -5,307,000.00 | 15,347,000.00 |
| Increase (decrease) in cash and cash equivalents after effect of exchange rate changes | N/A | -50,000.00 | -113,000.00 |
| Cash and cash equivalents | 191,000.00 | 141,000.00 | 28,000.00 |
Please note that some sums might not add up.
IT0005516130
815600CE609AFE44D992
Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.